Trupanion (NASDAQ:TRUP) Price Target Cut to $95.00 by Analysts at Piper Sandler

Trupanion (NASDAQ:TRUPGet Rating) had its price objective reduced by equities researchers at Piper Sandler from $150.00 to $95.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 37.70% from the company’s previous close.

Several other analysts also recently weighed in on the company. Lake Street Capital dropped their price objective on Trupanion from $150.00 to $120.00 in a research report on Thursday, February 17th. Bank of America dropped their price objective on Trupanion from $118.00 to $110.00 and set a “buy” rating for the company in a research report on Wednesday, April 20th. Zacks Investment Research upgraded Trupanion from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a research report on Wednesday, April 20th. TheStreet downgraded Trupanion from a “c-” rating to a “d+” rating in a research report on Wednesday, April 6th. Finally, StockNews.com initiated coverage on Trupanion in a research report on Thursday, March 31st. They set a “sell” rating for the company. One equities research analyst has rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $110.60.

NASDAQ:TRUP opened at $68.99 on Friday. The stock has a fifty day moving average price of $83.78 and a 200-day moving average price of $102.37. The company has a market cap of $2.79 billion, a price-to-earnings ratio of -78.40 and a beta of 2.06. Trupanion has a fifty-two week low of $65.94 and a fifty-two week high of $158.25.

Trupanion (NASDAQ:TRUPGet Rating) last released its earnings results on Wednesday, February 16th. The financial services provider reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.10. Trupanion had a negative return on equity of 9.69% and a negative net margin of 5.08%. The firm had revenue of $194.38 million during the quarter, compared to the consensus estimate of $193.09 million. During the same period in the prior year, the company posted ($0.09) EPS. The company’s revenue was up 36.2% compared to the same quarter last year. On average, analysts expect that Trupanion will post -0.62 EPS for the current fiscal year.

In related news, Director Michael Doak sold 700 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $97.26, for a total transaction of $68,082.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction on Friday, February 4th. The shares were sold at an average price of $90.51, for a total transaction of $362,040.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,008 shares of company stock worth $2,422,408. Insiders own 6.77% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. FNY Investment Advisers LLC acquired a new position in shares of Trupanion during the 4th quarter valued at $28,000. Rational Advisors LLC lifted its position in shares of Trupanion by 112.5% during the 4th quarter. Rational Advisors LLC now owns 238 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 126 shares during the period. Lindbrook Capital LLC acquired a new position in shares of Trupanion during the 4th quarter valued at $36,000. Harbor Investment Advisory LLC lifted its position in shares of Trupanion by 33.5% during the 1st quarter. Harbor Investment Advisory LLC now owns 714 shares of the financial services provider’s stock valued at $64,000 after acquiring an additional 179 shares during the period. Finally, Dark Forest Capital Management LP acquired a new position in shares of Trupanion during the 3rd quarter valued at $66,000. Institutional investors own 83.46% of the company’s stock.

About Trupanion (Get Rating)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

The Fly logo

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.